Year : 2019 | Volume
: 67 | Issue : 10 | Page : 1622--1623
Commentary: Understanding angiogenic factors in pathogenesis of persistent fetal vasculature
Sudarshan Khokhar, Chirakshi Dhull
Dr Rajendra Prasad Centre for Ophthalmic Sciences, All India Institute of Medical Sciences, New Delhi, India
Dr. Chirakshi Dhull
Room 486, Dr Rajendra Prasad Centre for Ophthalmic Sciences, All India Institute of Medical Sciences, Ansari Nagar, New Delhi - 110 029
|How to cite this article:|
Khokhar S, Dhull C. Commentary: Understanding angiogenic factors in pathogenesis of persistent fetal vasculature.Indian J Ophthalmol 2019;67:1622-1623
|How to cite this URL:|
Khokhar S, Dhull C. Commentary: Understanding angiogenic factors in pathogenesis of persistent fetal vasculature. Indian J Ophthalmol [serial online] 2019 [cited 2019 Nov 15 ];67:1622-1623
Available from: http://www.ijo.in/text.asp?2019/67/10/1622/267376
Persistent fetal vasculature (PFV) is a congenital pathology where remnants of the hyaloid artery system fail to regress. Presentation varies from anterior, posterior, or mixed variety based on structures involved from pupil and lens to optic disc. Anterior presentation includes persistent pupillary membrane, enlarged ciliary processes, cataract, capsular plaque with vessels, retrolental membrane, glaucoma, and/or Mittendorf dot. Posterior presentation includes Bergmeister's papilla, PFV stalk, falciform fold, and/or retinal detachment. The most common is the mixed variety where there is overlap of anterior and posterior presentation.
During fetal development, hyaloid artery system provides circulation of oxygen and nutrients throughout the eye (both anterior and posterior segments). It starts developing in the first month, and by third month, there are extensive vascular anastomosis present., The regression of vessels by apoptosis starts by the fifth month of gestation and normally completes by birth. If it fails to regress by birth, it leads to PFV and associated abnormalities. The reasons for failure of regression are incompletely understood. These vessels which persists after birth ooze at the time of surgery and result in complications. Presence of pink hue from capsular plaque known as “salmon patch sign”, is suggestive of PFV.
This study introduces an interesting hypothesis. Antiangiogenic factors (arresten, canstatin, tumstatin, and endostatin) and regulatory molecules such as matrix metalloproteinase (MMP) 2 and 9 which are evaluated in the study are hypothesized to have a role in PFV. These are collagen-derived antiangiogenic factors present in lens epithelial cells and hence can be studied in capsulorhexis sample.
Various studies have been conducted in the past to understand pathogenesis and the role of various factors in animal models. In these studies, angiogenic factors including vascular endothelial growth factor and placental growth factor have been noted to have a modulatory role in hyaloid regression. In addition, in macrophage-ablated mouse, persistence of the hyaloid vessels and the pupillary membrane has been noted, which is a direct evidence that the macrophage plays a role in the regression of these vessels. Persistent hyaloid artery also occurs in p53-deficient and Bax/Bak proapoptotic Bcl-2-deficient mice, hence implicating them in pathogenesis. The existing literature provides evidence that angiogenic and apoptotic factors have a role in regression of hyaloid artery system.
Antiangiogenic factors such as arresten and regulatory molecules (MMP-2 and MMP-9) have not been studied previously. The current study has found significantly lower level of arrestin mRNA and higher level of MMP-2, tumstatin, and canstatin. Since arresten, a known antiangiogenic factor, is found significantly low in the study, it is speculated to have a more important role than other factors. The reason for this is not fully understood. The major shortcoming of this study is a small sample size (13 eyes) and wide age of presentation chosen (1–108 months); which may affect the results. To validate the results and draw a satisfactory conclusion, a study should be designed to include more eyes with narrow age group (preferably in the first 3 months) for both cases and controls. Since capsulorhexis samples cannot be derived from clear lens, cadaveric eyes with clear lens may be alternate for control.
There is limited literature on use of capsulorhexis tissue for molecular studies. Hence, this study provides a human model where capsulorhexis tissue can be used in better understanding of lenticular abnormalities associated with a preexisting pathology including PFV, capsular plaques, toxoplasma, rubella, cytomegalovirus and herpes (TORCH) infections, and so on. It would be interesting to use such models in various ocular abnormalities in future research.
|1||Goldberg MF. Persistent fetal vasculature (PFV): An integrated interpretation of signs and symptoms associated with persistent hyperplastic primary vitreous (PHPV). LIV Edward Jackson Memorial Lecture. Am J Ophthalmol 1997;124:587-626.|
|2||Wright KW. Embryology. In: Cook CS, Sulik KK, Wright KW, editors. Pediatric Ophthalmology and Strabismus. St. Louis, MO: Mosby; 1995. p. 1-43.|
|3||Balazs EA, Toth LZ, Ozanics V. Cytological studies on the developing vitreous as related to the hyaloid vessel system. Albrecht Von Graefes Arch Klin Exp Ophthalmol 1980;21371-85.|
|4||Mullner-Eidenbock A, Amon M, Moser E, Klebermass N. Persistent fetal vasculature and minimal fetal remnants: A frequent cause of unilateral congenital cataracts. Ophthalmology 2004;111:906-13.|
|5||Khokhar S, Gupta S, Gogia V, Nayak B. Salmon pink patch sign: diagnosing persistent fetal vasculature. Oman J Ophthalmol 2016;9:68-9.|
|6||Gajjar DU, Vasavada AR, Patel P, Praveen MR, Shah SR. Evaluation of collagen derived antiangiogenic factors and matrix metalloproteinases in anterior lens epithelial cells of pediatric eyes with persistent fetal vasculature. Indian J Ophthalmol 2019;67:1618-22.|
|7||Feeney SA, Simpson DA, Gardiner TA, Boyle C, Jamison P, Stitt AW. Role of vascular endothelial growth factor and placental growth factors during retinal vascular development and hyaloid regression. Invest Ophthalmol Vis Sci 2003;44:839-47.|
|8||Lang R, Lustig M, Francois F, Sellinger M, Plesken H. Apoptosis during macrophage-dependent ocular tissue remodeling. Development 1994;120:3395-403.|
|9||Hahn P, Lindsten T, Tolentino M, Thompson CB, Bennett J, Dunaief JL. Persistent fetal ocular vasculature in mice deficient in bax and bak. Arch Ophthalmol 2005;123:797-802.|